Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib

Blood23.10
Volume: 133, Issue: 14, Pages: 1597 - 1606
Published: Jan 28, 2019
Paper Details
Title
Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
Published Date
Jan 28, 2019
Journal
Volume
133
Issue
14
Pages
1597 - 1606
© 2026 Pluto Labs All rights reserved.